510(k) K050613

QUANTIA BETA-2 MICROGLOBULIN by Biokit, S.A. — Product Code JZG

K050613 is an FDA 510(k) premarket notification submitted by Biokit, S.A. for the device "QUANTIA BETA-2 MICROGLOBULIN". The FDA issued a decision of Substantially Equivalent on August 16, 2005. The device falls under product code JZG (System, Test, Beta-2-Microglobulin Immunological), a Class II device regulated under 21 CFR 866.5630. Biokit, S.A. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 16, 2005
Date Received
March 10, 2005
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Test, Beta-2-Microglobulin Immunological
Device Class
Class II
Regulation Number
866.5630
Review Panel
IM
Submission Type